Clinical Trials Directory

Trials / Completed

CompletedNCT04735848

Plasma Hepcidin Response to Differently Dosed Iron Supplements

Single Center Clinical Trial to Evaluate the Effect of Different Amounts of Iron Supplements on the Plasma Hepcidin Level in Non-anemic Iron-deficient Females

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
Pierre-Alexandre Krayenbuehl · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The study participants will take 3 different doses of iron supplements at 8 am, on 3 different days. By taking blood samples in the morning and afternoon, the investigators will determine the effects of the iron supplements on plasma hepcidin and compare them to baseline plasma hepcidin values.

Detailed description

15 healthy young women with non-anemic iron deficiency will participate in the study. On 4 different days the investigators will take two blood samples (one in the morning at 8 am, before the iron intake and one in the afternoon at 4 pm) to determine the plasma hepcidin level. The intake of the iron supplements will be at least 48 hours apart from each other, to exclude any impacts of the previous iron intake to the next measurement. The participants will take the iron supplement supervised at 8 am after overnight fasting. All blood samples will be performed for analysis of CRP and hepcidin. The investigators will measure the CRP in the blood sample to exclude any impacts of inflammation to the hepcidin measurement and use a CRP ≤5mg/l as a cut-off. If the CRP is higher than 5mg/l the investigators will exclude the measurement from our analyses and repeat the measurement at another day. The first two blood samples will be taken at 8 am and at 4 pm on the same day and after overnight fasting to find the baseline hepcidin, the other blood samples will be taken at 8 am before the iron intake and at 4 pm also on the same day and also after overnight fasting.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIron-supplement applicationThe participants will take the corresponding amount of iron-supplement supervised at 8am.

Timeline

Start date
2021-06-01
Primary completion
2021-08-31
Completion
2021-08-31
First posted
2021-02-03
Last updated
2021-10-08

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04735848. Inclusion in this directory is not an endorsement.